Delivery Order SPE2DB20D2104-SPE2DB25FNAZD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) under a firm fixed-price contract valued at $2,134.02. The order was competitively awarded without a set-aside designation and carries an ultimate completion date of July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $4,775.51 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) on September 5, 2025, with completion expected by September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) under a firm fixed price contract valued at $5,184.10. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 20, 2025. AmerisourceBergen will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,188.39 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packaging) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) valued at $3,581.91. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is due for completion by September 19, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,350.29 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages) on April 25, 2025, with completion scheduled for April 28, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $8,721.60. This firm fixed-price delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026. The award was competitively made with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,922.04 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and is being performed at the contractor's Conshohocken, Pennsylvania location. The award is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,552.14 to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count packaging). This firm fixed-price, competitively awarded contract was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,926.42 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (quantity 60s) on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed price delivery order represents a non-set-aside award executed through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's pharmaceutical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNAZDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Brilinta 90 mg tablets in a 60-count configuration. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $10,236.96 and an ultimate completion date of September 22, 2025. The award was issued on September 19, 2025, with no set-aside designation applied. As a child contract action, this delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen serves as a critical federal medical vendor, supplying pharmaceuticals and medical commodities across multiple therapeutic domains to support military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements through open competition. Brilinta, an antiplatelet medication commonly used in cardiovascular treatment protocols, represents one component of the company's broader pharmaceutical supply mission under the DLA Troop Support Medical contract vehicle, which enables global pharmaceutical support for military healthcare programs and other government healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 9/19/25 |